Platform technologies to enable rapid vaccine development for epidemic prone infections
In this two-step call, CEPI asked for submission of proposals for vaccine platform technologies that enable rapid vaccine development for reactive use in outbreaks of for novel or previously unrecognised viruses with outbreak potential.
- Submission deadline for Step 1 proposals was 4 p.m. Central European Summer Time 17 October 2017 and this stage is now closed
- The CfP-2 Step 1 review process of preliminary applications has concluded, and shortlisted candidates have been invited to submit full proposals
- Deadline for submission of Step 2 proposals is 3 p.m. Central European Time 27 February 2018
- Please do not submit an application if you have not been invited to Step 2 of this CfP
Responses to CEPI's second call for proposals
On 1st September, CEPI launched its Second Call for Proposals (CfP) on Vaccine platform technologies to promote the objective of developing development of real time response capabilities to novel emerging threats, and immunize at-risk populations against emerging infectious diseases, potentially resulting in great public health impact by rapidly limiting or ending outbreaks.
In response to this Call for Proposals, the Secretariat received over 35 applications by the deadline of 17 October, with a broad diversity displayed in the vaccine platform technologies being proposed, including both novel concepts and established technologies. All eligible submissions are now being evaluated, and shortlisted applicants will be notified in December to submit detailed proposals in early 2018.
Similar to our previous call, applicants and their partners are from North America, South America, Europe, Africa, Asia and Australia, representing academic institutions, biotechs, large pharmaceutical companies and Product Development Partnerships.More information
Work on Ebola
The "Ebola vaccines regulatory scientific meeting" enabled us to look into future regulatory scientific research areas which will be further refined and taken forward in smaller task forces. Updates on how we will proceed the work on Ebola will be published on our website and Newsletter.
The summary report can be found here.
Additionally, we would like to also draw the attention of interested stakeholders to the current open IMI 2 – call 8 on “Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks”. This call is open for a period of 2 years with different cut-off dates. The remaining cut-off dates are 14 September 2017 and 15 March 2018.
For more information, please follow this link.